Kaiming Wu

Kaiming Wu

Auto-generated profile, based on publicly available information

Kaiming Wu

Department of Thoracic Surgery the First Affiliated Hospital of Anhui Medical University Hefei China

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 February 2019 in Disease Markers
Verified
Journal Article
Open access
PDF file
LYLong Yao
Long Yao
MLMengke Liu
Mengke Liu
YHYunlong Huang
Yunlong Huang
KWKaiming Wu
Kaiming Wu
XHXin Huang
Xin Huang
RZRenquan Zhang
Renquan Zhang
Background. Antidiabetic medications (ADMs) can alter the risk of different types of cancer, but the relationship between lung cancer incidence and metformin remains controversial. Our aim was to quantitatively estimate the relationship between incidences of lung cancer and metformin in patients with diabetes in this meta-analysis. Methods. We performed a search in PubMed, Embase, ISI Web of Science, and Cochrane Library until September 20, 2017. The odds ratio (OR), relative risk (RR) or hazard ratio (HR), and 95% confidence interval (95% CI) were estimated using the random-effect model. The Newcastle-Ottawa Scale (NOS) was used to assess the study quality. Results. A total of 13 studies (10 cohort studies and 3 case-control studies) were included in the meta-analysis. Compared to nonmetformin users, metformin probably decreased lung cancer incidence in diabetic patients (RR=0.89; 95% CI, 0.83-0.96; P=0.002) with significant heterogeneity (Q=35.47, I2=66%, P=0.0004). Subgroup analysis showed that cohort studies (RR=0.91; 95% CI, 0.85-0.98; P=0.008), location in Europe (RR=0.90; 95% CI, 0.86-0.94; P<0.0001), the control drug of the sulfonylurea group (RR=0.91; 95% CI, 0.86-0.96; P=0.001), and adjusting for smoking (RR=0.86; 95% CI, 0.75-1.00; P=0.05) may be related to lower lung cancer risk. No significant publication bias was detected using a funnel plot. Conclusion. Metformin use was related to a lower lung cancer risk in diabetic patients compared to nonusers, but this result was retrieved from observational studies and our findings need more well-designed RCTs to confirm the association.

21 October 2021 in Journal of Gastroenterology and Hepatology
Verified
Journal Article
Closed access
PDF file
KWKaiming Wu
Kaiming Wu
ZWZiao Wang
Ziao Wang
YHYunlong Huang
Yunlong Huang
LYLong Yao
Long Yao
NKNingning Kang
Ningning Kang
Wei HeWei He
Wei He